Company / Free Cash Flow
PUMA BIOTECHNOLOGY, INC. Free Cash Flow History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
$26.9M
FY2025
5-year range
-$15.8M / $26.9M
FY2021-FY2025
Trend
+269.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow changed +270% YoY in FY2025, a notable deviation from the 8-year average annual change of +375%.
Based on SEC 10-K filings.
$27M in FY2025 with a 3-year CAGR of +233.1%.
Improved from $21M to $27M over the past 2 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- +233.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +233.1%, indicating consistent growth.
- In FY2025, free cash flow increased 269.8% year-over-year.
- Lowest free cash flow in the period was in FY2019.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $26.9M | +269.8% |
| FY2024 | -$15.8M | -176.6% |
| FY2023 | $20.6M | +2740.4% |
| FY2022 | $727.0K | -96.7% |
| FY2021 | $22.1M | +190.9% |
| FY2020 | -$24.3M | +85.9% |
| FY2019 | -$172.6M | -18.3% |
| FY2018 | -$146.0M | +6.1% |
| FY2017 | -$155.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026